BCRX
NASDAQ · Biotechnology
Biocryst Pharmaceuticals Inc
$8.62
-0.28 (-3.15%)
Open$8.96
Previous Close$8.90
Day High$8.99
Day Low$8.56
52W High$11.31
52W Low$6.00
Volume—
Avg Volume3.90M
Market Cap2.18B
P/E Ratio8.26
EPS$1.20
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+667.1% upside
Current
$8.62
$8.62
Target
$66.12
$66.12
$46.17
$66.12 avg
$78.89
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.01B | 684.12M | 328.14M |
| Net Income | 305.05M | 185.71M | -56,674,354 |
| Profit Margin | 30.2% | 28.7% | -17.3% |
| EBITDA | 389.75M | 250.46M | -75,730,538 |
| Free Cash Flow | — | — | -52,199,092 |
| Rev Growth | +47.8% | +47.8% | +7.1% |
| Debt/Equity | 2.09 | 2.09 | 0.16 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |